Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern

Phase

N/A

Condition

Sleep Apnea Syndromes

Treatment

CPAP treatment

Clinical Study ID

NCT03948373

Dipper-OSA

Ages 18-100
All Genders

Study Summary

The principal objective is to evaluate the effect of CPAP treatment on blood pressure (BP) in normotensive patients with dipper circadian pattern with sleep apnea-hypopnea syndrome (SAHS). The secondary objectives are: i) To evaluate the prevalence of the different circadian patterns of BP in ambulatory blood pressure monitoring (ABPM) ii) To establish the relationship between CPAP compliance and BP response; iii) Identify which ABPM variables and biomarkers are related to BP response; iv) Evaluate changes in the biomarkers' profile with the CPAP treatment. Methodology: Open-label, parallel, prospective, randomized and controlled trial including normotensive patients diagnosed with severe SAHS without significant somnolence. 64 patients with dipper circadian pattern will be included and will be randomized to receive CPAP (32) or conservative treatment (32). ABPM and blood sample collection will be performed at the beginning of the study and at 3 months.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Men and women over 18 years of age
Referred to the sleep unit for suspected OSA
Being normotensive and presenting an AHI ≥ 30 in the sleep study
Signature of the informed consent.

Exclusion

Exclusion Criteria:

Previous CPAP treatment
Significant somnolence defined by an Epworth Sleepiness Scale (ESS) score higherthan 18
Psychophysical inability to complete questionnaires
Previous diagnosis or suspicion of another sleep disorder
Presence of more than 50% of central apneas or Cheyne-Stokes respiration
Having a serious chronic disease: neoplasia, renal failure, severe chronicobstructive pulmonary disease, chronic depression and other chronic limitingdiseases
Medical history that may interfere with the objectives of the study or, in theopinion of the researcher, may compromise the conclusions
Any medical, social or geographical factor that may endanger the patient'scompliance 9-Having a profession of high risk (professional driver).

Study Design

CPAP treatment

May 07, 2019

December 31, 2025

Study Description

Recruitment: Normotensive subjects referred to the sleep unit of the Hospital Santa Maria (Spain) who are diagnosed of severe OSA (AHI≥30) by a sleep study and dipper circadian blood pattern confirmed by ABPM and who do not present significant somnolence (Epworth≤18) will be included in the study.
Definition of the groups: Patients will be randomized to receive one of the following treatments:
1. CPAP: Patients who will receive CPAP treatment. The CPAP titration will be carried out with an automatic or manual CPAP according to usual clinical practice.
2. Conservative treatment: Patients who will receive conservative treatment based on hygienic-dietetic measures.
Randomization: It will be carried out with an automated platform
Duration of the treatment: All patients randomized to CPAP will begin treatment as soon as possible after randomization, and will continue treatment until the study ends (3 months).

Patients who interrupt treatment will be excluded from the study. ABPM and blood sample collection will be performed on all included patients at the beginning of the study and at 3 months under treatment (CPAP or conservative care).
Follow-up: All patients will be evaluated at the beginning of the study (T0), at first month (T1) and at three months (T2), during the follow-up period.

Connect with a study center

Hospital Arnau de Vilanova-Santa Maria
Lleida, 25198
Spain
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.